Exelixis Inc. buy BiotechBee
Start price
08.09.24
/
80%
€23.18
Target price
31.12.26
€30.00
Performance (%)
45.56%
End price
14.12.24
€33.74
Summary
This prediction ended on 14.12.24 with a price of €33.74. With a performance of 45.56% the BUY prediction by BiotechBee was a big success. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | 5.577% | 5.577% | 11.420% |
| iShares Core DAX® | 2.489% | -5.941% | 2.896% |
| iShares Nasdaq 100 | 1.649% | -2.462% | 15.754% |
| iShares Nikkei 225® | 0.555% | -7.597% | 30.353% |
| iShares S&P 500 | 1.347% | -2.943% | 10.338% |
According to BiotechBee what are the pros and cons of Exelixis Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Exelixis Inc. diskutieren
Buy mit Kursziel 30,0
In the thread Trading Exelixis Inc.
Buy beendet

